Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in ...
An analysis of SpringWorks Therapeutics, Inc., including recent FDA approval, promising sales, and future funding for ...
The UAB MGL has lifted the moratorium on the RNA-based biopsy testing of neurofibroma tumor samples (test code: NF14N). Clinical samples for NF14N testing can now be accepted. For all cell ...
A doctor may suspect a plexiform neurofibroma based on a physical examination and your medical history. However, additional tests are usually needed to confirm the diagnosis and determine the extent ...
引言I型神经纤维瘤病(NF1)是由NF1基因突变引起的常染色体显性遗传性疾病,患病率约为1/4000-1/2000,患者多幼年起病,临床表现以咖啡牛奶斑和多发性神经纤维瘤为特征[1]。其中约50%的患者会出现丛状纤维神经瘤(PN)[2],NF1-PN ...
angiosarcoma), lymphatics (lymphangiosarcoma), nerves (Schwannoma and neurofibroma), adipose tissue (liposarcoma) and smooth or skeletal muscle (leiomyosarcoma, rhabdomyosarcoma). As spindle cells ...